JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance

U.S. Markets closed

Johnson & Johnson (JNJ)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
118.86+0.78 (+0.66%)
At close: 4:00PM EST
People also watch
PGMRKKOPFEXOM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close118.08
Open118.19
Bid0.00 x
Ask0.00 x
Day's Range118.05 - 118.90
52 Week Range102.97 - 126.07
Volume8,691,397
Avg. Volume6,926,209
Market Cap323.36B
Beta0.64
PE Ratio (TTM)20.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.20 (2.69%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com3 hours ago

    The Natural Food Craze Is Now Sweeping Into Personal Care Products

    Demand for 'green' consumer products is rising and giants like Procter & Gamble are noticing.

  • Better Buy: Eli Lilly and Company vs. Johnson & Johnson
    Motley Foolyesterday

    Better Buy: Eli Lilly and Company vs. Johnson & Johnson

    Which healthcare stock wins in a head-to-head match-up between Eli Lilly and Johnson & Johnson?

  • American City Business Journals2 days ago

    ​Ethicon to acquire competitor

    Ethicon, a Blue Ash firm that makes medical tools used for surgery, revealed today that it has entered into an agreement to acquire competitor Torax Medical Inc. Ethicon, which is a division of New Jersey-based Johnson & Johnson (JNJ), expects to close on the deal by the end of March. Torax Medical, a privately held firm based in Shoreview, Minn., has estimated annual revenue of $15.9 million.